aluminum sulfate has been researched along with Disease Resistance in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcain, J; Álvarez, DE; Auguste, AJ; Bruno, LA; Cassataro, J; Castro, EF; Chemes, LB; Coria, LM; Darriba, ML; Mazzitelli, I; Pasquevich, KA; Pérez, PS; Pueblas Castro, C; Salvatori, M; Saposnik, LM; Stone, WB; Varese, A | 1 |
1 other study(ies) available for aluminum sulfate and Disease Resistance
| Article | Year |
|---|---|
A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Neutralizing; Antibodies, Viral; Antibody Formation; B-Lymphocytes; Bacterial Outer Membrane Proteins; Brucella; COVID-19; COVID-19 Vaccines; Disease Resistance; Female; Germinal Center; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2022 |